2019ÄêÖÐÒ½Ò©»ù´¡Ñо¿Å̵ã
À´Ô´£ºBOB¼¯Íż¯ÍÅ ÈÕÆÚ£º2020.01.08 ä¯ÀÀÁ¿£º2956
    Ò½Ò©Íø1ÔÂ8ÈÕѶ¡¡ÔڿƼ¼ÈÕÒæ½ø²½¡¢¾­¼Ã·ÉËÙ·¢Õ¹µÄ½ñÌ죬ÖÐÒ½Ò©Ò²×ßµ½Á˹ú¼Ê»ù´¡¿ÆÑеľº¼¼³¡ÉÏ¡£»Ø¹ËÒѾ­¹ýÈ¥µÄ2019Ä꣬¹ú¼ÊºËÐÄÆÚ¿¯¿¯·¢ÖÐÒ½Ò©Ïà¹ØÎÄÏ××ܼƴï2193ƪ£¬Õ¼ÀúÄêÖÐÒ½Ò©ÁìÓò¿ÆÑÐÎÄÏ××ÜÊýµÄ12.02%¡£ºÁ²»¿äÕŵØËµ£¬ÖÐÒ½Ò©ÏÖ´ú»¯´´Ð³ɹû10%ÒÔÉϵÄÀúÊ·ÊÇÔÚ2019ÄêÊéдµÄ£¨±í1£©¡£

 
    ÁÁµã1£ºÖÐÒ½Ò©ÌåϵÄÉÈëÊÀ½çҽѧ·ÖÀàÌåϵ
 
    2019Äê5ÔÂ25ÈÕµÚ72½ìÊÀ½çÎÀÉú´ó»áÉóÒéͨ¹ýµÄ¡¶¹ú¼Ê¼²²¡·ÖÀàµÚʮһ´ÎÐÞ¶©±¾£¨ICD-11£©¡·£¬Ê×´ÎÄÉÈëÆðÔ´ÓÚÖÐÒ½Ò©µÄ´«Í³Ò½Ñ§Õ½Ú£¬ÕâÊÇÎÒ¹úÕþ¸®ÓëÖÐҽҩר¼ÒÀú¾­Ê®ÓàÄê³ÖÐøÅ¬Á¦ËùÈ¡µÃµÄ±¦¹ó³É¹û¡£
 
    ¹ú¼Ê¼²²¡·ÖÀࣨICD£©ÊÇÊÀ½çÎÀÉú×éÖ¯£¨WHO£©Öƶ¨°ä²¼µÄ¡¢¹ú¼ÊͳһµÄ¼²²¡·ÖÀà±ê×¼£¬ÊǸ÷¹úÕþ¸®ÔÚÒ½ÁÆ¡¢¹ÜÀí¡¢½ÌѧºÍ¿ÆÑм°Öƶ¨Õþ²ßÖйØÓÚ¼²²¡·ÖÀàµÄ¹æ·¶ÐÔ±ê×¼£¬ÊÇÈ«ÇòÎÀÉú½¡¿µÁìÓò¾ßÓÐȨÍþÐԵĻù´¡ºÍͨÓñê×¼Ö®Ò»¡£I CDÀú¾­°ÙÄ꣬ÒѽøÐÐÊ®Óà´ÎÐÞ¶©¡£ÔÚI CD-11Öн¨Á¢ÁËÒÔÖÐҽҩΪ»ù´¡¡¢¼æ¹ËÈÕº«´«Í³Ò½Ñ§ÄÚÈݵIJ¡Ö¤·ÖÀàÌåϵ£¬Íƶ¯ÁË´«Í³Ò½Ñ§150Ìõ¼²²¡ºÍ196ÌõÖ¤ºò£¨²»º¬ÌØÖ¸ºÍ·ÇÌØÖ¸²¡Ö¤£©ÌõÄ¿ÄÉÈëI CD-11´«Í³Ò½Ñ§Õ½Ú¡£
 
    ICD-11µÄ·¢²¼£¬ÓÐÖúÓÚÎÒ¹ú½¨Á¢Óë¹ú¼Ê±ê×¼ÏàÏνӲ¢ÌåÏÖÎÒ¹úÖÐÒ½Ò©ÎÀÉú·þÎñÐÅÏ¢µÄͳ¼ÆÍøÂ磬´Óͳ¼Æ·ÖÎöµÄ½Ç¶ÈÕÃÏÔÎÒ¹úÖÐÒ½Ò©·þÎñÔÚÈËÀཡ¿µ·þÎñÖеÄÄÜÁ¦ºÍµØÎ»£¬ÓÐÀûÓÚÖÐÒ½Ò©¹ú¼Ê½»Á÷ÓëºÏ×÷£¬´Ù½øÖÐÒ½Ò©ÓëÊÀ½ç¸÷¹úÒ½ÁÆÎÀÉúÌåϵÈںϷ¢Õ¹£¬ÎªÊÀ½ç¸÷¹úÈÏʶ¡¢Á˽⡢ʹÓÃÖÐÒ½Ò©µì¶¨Á˼áʵ»ù´¡£¬¾ßÓзdz£ÖØÒªµÄÏÖʵÒâÒåºÍ¼«ÎªÉîÔ¶µÄÀúÊ·ÒâÒå¡£
 
    ÁÁµã2£º»ÆÁ¬ÌáÈ¡ÎïСéÞ¼îÖÎÁÆÌÇÄò²¡Ð§¹ûÏÔÖø
 
    ÔÚ¼²²¡ÖÎÁÆÏà¹ØÑо¿·½Ã棬ÖÐÒ½Ò©ÖÎÁÆ×îÈÈÃÅÁìÓò°üÀ¨°¢¶û´Äº£Ä¬²¡¡¢¸Îϸ°û°©¡¢ÈéÏÙ°©ºÍÌÇÄò²¡µÈ£¬ÆäÖÐÓйØÖÐÒ½Ò©ÔÚÌÇÄò²¡ÁìÓòµÄ¿ÆÑ§ÎÄÏ×£¬ÎÞÂÛÔÚÀúÊ·´¢±¸ºÍÐÂÔöÁ¿Öоù´¦ÓÚ¾ø¶ÔÖ÷µ¼µØÎ»£¨±í2£©¡£Êý¾ÝÏÔʾ£¬2019Ä꣬ÌÇÄò²¡ÁìÓòÐÂÔöÖÐÒ½Ò©Ïà¹Ø¿ÆÑÐÎÄÏ×Õ¼±È¸ß´ï47.66%£¬ÆäÓàÈýÖÖ¼²²¡µÄ¿ÆÑÐÎÄÏ×ÐÂÔöÊýÁ¿Õ¼±È²»µ½20%¡£
 
 
    Óɴ˿ɼû£¬ÌÇÄò²¡ÁìÓòÊÇÎÒ¹úÖÐÒ½Ò©×îÊʺϵÄÇÐÈëÁìÓò¡£2019Ä꣬ÉϺ£½»Í¨´óѧ¸½ÊôµÚÁùÈËÃñÒ½Ôº¼Öΰƽ½ÌÊÚÔÚÊÀ½çÖªÃûÆÚ¿¯¡¶Advanced Drug Delivery Reviews¡··¢±í×ÛÊöÎÄÏס¶Therapeutic medications against diabetes£º What we have and what we expect¡·¡£ÎÄÖп϶¨ÁËÒÔÖÐÒ©Ö²ÎïΪ´ú±íµÄÌìÈ»²úÎïÌáÈ¡ÎïÔÚѪÌÇ¿ØÖÆÖеÄ×÷Óã¬ÓÈÆäÊÇÀ´Ô´ÓÚÖÐÒ©»ÆÁ¬µÄÌáÈ¡ÎïСé޼±»ÈÏΪÄܹ»Í¨¹ýÔö¼ÓÆÏÌÑÌǼ¤Ã¸»îÐÔÀ´´Ì¼¤Ìǽͽ⣬Ôö¼ÓÒȵºËØ·ÖÃÚ£¬ÒÖÖÆ¸ÎÔàÌÇÖÊÐÂÉú£¬²¢Í¨¹ý´Ì¼¤ÏÙÜÕËἤ»îµ°°×¼¤Ã¸£¨AMPK£©ÓÕµ¼Ö¬·¾²úÉú¡£
 
    ÁÁµã3£º×ÏÝÒ¿¹Ö×Áö»îÐԳɷÖastins¹æÄ£»¯Éú²ú³ÉΪ¿ÉÄÜ
 
    »·ëÄastinsÊÇ×ÏÝұȽÏÓÐÌØÉ«µÄÒ»À໯ѧ³É·Ö£¬Æä½á¹¹ÐÂÓ±£¬ÊÇ×ÏÝÒ¿¹Ö×Áö»îÐÔµÄÖ÷Òª³É·Ö£¬ÔÚÖ²Îï·ÖÀàѧ¼°¿¹Ö×ÁöÐÂÒ©¿ª·¢É϶¼¾ßÓнϸߵÄÑо¿¿ª·¢¼ÛÖµ¡£
 
    ÓÉÓÚ¸ÃÀà²úÎï½á¹¹ÐÂÓ±£¬ÔøÒ»¶È±»ÈÏΪֻÓÐÔÚ×ÏÝÒÀàÖ²ÎïÖвÅÄܲúÉú¡£2019Äê12ÔÂ6ÈÕ£¬À´×Ե¹úµÂÀÛ˹¶Ù¹¤Òµ´óѧµÄJutta Ludwig-M ül l er½ÌÊÚÍŶÓÔÚÃÀ¹ú¿ÆÑ§ÔºÔº±¨ÉÏ·¢±íÎÄÕ¡¶Antitumor  astins originate from the fungal endophyte Cyanodermella  asteris  living within the medicinal plant Aster tataricus¡·£¬±íʾÕÒµ½Á˸ÃÀà»·ëĵÄÕæ¾úÀ´Ô´¡£
 
    Ñо¿ÍŶӷ¢ÏÖ£¬Ä³Ð©Äܹ»²úÉúastinsµÄÖ²Îï¿ÉÄÜÓëÀ¶ÔåÄÚÉúÕæ¾úÃÜÇÐÏà¹Ø£¬¶ÔÕâÀàÖ²Îï½øÐзÖÀë¿ÉµÃµ½Ö²Îï²úÎïA.astinsµÄǰÌåÎïÖÊC.astins£¬²¢×îÖÕÈ·¶¨Õæ¾úLecanoromycetesÊÇ»·ëÄastinsµÄÖ÷ÒªÀ´Ô´£¬¸ÃÕæ¾úÖ÷Ҫͨ¹ýÓëÖ²Îï¹²ÉúµÄ·½Ê½²úÉúastinsÀ໯ºÏÎï¡£ÕâÒ»·¢ÏÖʹ¿ÆÑ§¼Ò»ñµÃÁËÔÚʵÑéÊÒ½øÐÐÎÞÍÁÉú²ú±ê×¼»¯astinsµÄÄÜÁ¦£¬²¢Îª¸ÃÀ໯ºÏÎïµÄ¹æÄ£»¯Éú²úµì¶¨ÁË»ù´¡¡£
 
    ÁÁµã4£ºéÎÆ¤ËØ¡¢±ûÏ©ËáÄÚõ¥¿É¸ÄÉÆ½áÖ±³¦°©»¼ÕßµÄÃâÒßÒÖÖÆ
 
    ΢ÎÀÐÇÓֳƼòµ¥Öظ´ÐòÁУ¬ÊÇ´æÔÚÓÚ»ùÒò×éÖеÄһЩСƬ¶ÎºËÜÕËáµÄÖØ¸´ÐòÁУ¬Öظ´µ¥Î»Ò»°ãÓÉ1¡«6¸öºËÜÕËá×é³É£¬Öظ´´ÎÊý²»³¬¹ý60´Î£¬¾ßÓиßÍ»±äÐÔ¡£DNAÔÚ¸´Öƹý³ÌÖУ¬ÓÈÆäÊÇ΢ÎÀÐÇ£¬¿ÉÄÜ»á³öÏÖ¼î»ù´íÅäµÈ´íÎó£¬ÕâЩ´íÎó»ýÀÛÆðÀ´²¢Ò»´ú´ú´«µÝÏÂÈ¥£¬×îÖÕ»á²úÉú»ùÒòÍ»±ä½ø¶øµ¼ÖÂϸ°û°©±ä¡£¶ø½áÖ±³¦°©ÖеÄ΢ÎÀÐDz»Îȶ¨ÏÖÏó±»ÈÏΪÄܹ»¸ÉÈÅÃâÒßÁÆ·¨£¬Ê¹ÁÙ´²ÓÃҩЧ¹û´ó´òÕÛ¿Û¡£ÓÐÑо¿±íÃ÷£¬°´ÕÕ1£º4µÄ±ÈÀý¸øÓ軼ÕßÖÐÒ©ÌáÈ¡ÎïéÎÆ¤ËغͱûÏ©ËáÄÚõ¥Äܹ»ÓÐЧ¸ÄÉÆ¸ÃÏÖÏ󣬵«ÊÇÏÖÓÐÁÙ´²ÌåÄÚ¸øÒ©Í¾¾¶ºÜÄÑ×öµ½¾«È·ÌåÄÚ¸øÒ©¡£
 
    ÓÉÃÀ¹ú±±¿¨ÂÞÀ´ÄÉ´óѧºÍÎÒ¹úÖйú¿ÆÑ§Ôº³¤´ºÓ¦Óû¯Ñ§Ñо¿ËùºÏ×÷Íê³ÉµÄÐÂÐÍÄÉÃ׸øÒ©ÏµÍ³£¬¹¥¿ËÁ˾«È·ÌåÄÚ¸øÒ©ÏµÍ³µÄ¼¼ÊõÄѹØ£¬ÆäÁÆÐ§ÒѾ­µÃµ½¶àÖÖÁÙ´²Ç°ÊµÑéÄ£Ð͵ÄÑéÖ¤£¬Ïà¹Ø³É¹û·¢±íÓÚÔÓÖ¾¡¶ACS Nano¡·¡£
 
    ÁÁµã5£º¶¬³æÏIJݾúË¿Ìå±»·¢ÏÖ¾ßÓп¹·ÊÅÖ×÷ÓÃ
 
    2019Äê2Ô£¬Ì¨Í峤¸ý´óѧÀµÐÅÖ¾½ÌÊÚÍŶÓÔÚѧÊõÆÚ¿¯¡¶Gut Microbiota¡··¢±íÂÛÎÄ¡¶Gut commensal Parabacteroides goldsteinii plays a predominant  rolein the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis¡·£¬³Æ¶¬³æÏIJݵÄË®ÌáÈ¡¶àÌDzúÎïÄܹ»ÓÐЧ½µµÍ¸ßÖ¬ÒûʳСÊóµÄ·ÊÅÖˮƽ¡£
 
    ¸ÃÍŶÓÑо¿·¢ÏÖ£¬´Ë¶àÌDzúÎï¸ÄÉÆ·ÊÅÖµÄÖ÷Òª»úÖÆÊÇͨ¹ýÖØËܳ¦µÀ¾úȺ»·¾³´Ó¶ø´ïµ½Ä¿µÄ£¬ÆäÖ÷Òª±ä»¯°üÀ¨Ôö¼ÓÁ˸ïÀ¼Êϸ˾úºÍÆäËûÐÂÃ¹ËØÃô¸Ð¾úµÄˮƽ£¬ÕâÖֱ仯·´¹ýÀ´ÓÖ»áÌáÉý¸ßÖ¬ÒûʳСÊóµÄ³¦µÀÍêÕûÐÔºÍÒȵºËØÃô¸ÐÐÔ£¬²¢×îÖÕ¼õÉÙ´úлÐÔÄÚ¶¾ËØÑªÖ¢¡¢Ñ×Ö¢¡¢Ö¬·¾³Á»ý¡¢Ö¬·¾×éÖ¯²¡Àí¼°Ö¬·¾¸ÎµÄ·¢Õ¹£¬Í¬Ê±¿ÉÒԴ̼¤»úÌå·¢ÈÈ£¬Ôö¼ÓÖ¬·¾ÏûºÄ¡£
 
    ÁÁµã6£ºÉÖÒ©ÜյĿ¹Ñ×¼°ÃâÒßµ÷½Ú¹¦Äܵõ½ÏµÍ³ÐÔ²ûÊö
 
    2019Äê2Ô£¬°²»Õ¿¹Ñ×ÃâÒßÒ©ÎïЭͬ´´ÐÂÖÐÐÄκΰ½ÌÊÚÍŶÓÔÚºËÐÄÆÚ¿¯¡¶Pharmacology and Ther apeutics¡·ÉÏ·¢±í×ÛÊöÎÄÕ¡¶Antiinflammatory and immunoregulatory  effects of paeoniflorin and total glucosides of paeony¡·£¬ÏµÍ³²ûÊöÁËÉÖÒ©ÜÕ¼°ÉÖÒ©×ÜÜÕÔÚ½üÄê¿ÆÑÐÖÐËùÈ¡µÃµÄÍ»ÆÆºÍÍêÕûµÄÉúÀíÒ©Àí×÷Óá£
 
    ×÷Õß»ùÓÚÔÚÉÖÒ©ÜÕÁìÓòµÄ¶àÄêÑо¿£¬ÈÏΪÉÖÒ©ÜÕ¾ßÓй㷺µÄ¿¹Ñ×¼°ÃâÒßµ÷½Ú×÷Óã¬Æä×÷Óñ»ÈÏΪºÍ¶àÌõϸ°ûÐźÅͨ·ÓйØ£¬ÆäÖаüÀ¨MAPKsÐźÅͨ·¡¢PI3K/ Akt/ mTORÐźÅͨ·¡¢JAK2/ STAT3ÐźÅͨ·¡¢TGFβ/ Smadsͨ·¡¢NF-κB ͨ·ºÍROS/ p38/ p53ͨ·µÈ¡£
 
    ¸ÃÍŶÓÔÚÑо¿ÖÐÌáʾ£¬ÉÖÒ©×ÜÜÕ¿ÉÄÜÊÇÒ»ÖÖÓÐDZÔڵĿ¹Ñס¢ÃâÒßµ÷½Ú×÷ÓõÄÒ©ÎÔÚÖÎÁÆ×ÔÉíÃâÒßÐÔ¼²²¡·½Ãæ¿ÉÄܱÈÉúÎïºÍ¼²²¡ÐÞÊο¹·çʪҩ£¨DMARDs£©¸üÓÐÓÅÊÆ¡£
 
    ³ý´ËÖ®Í⣬×÷ÕßÈÏΪÉÖÒ©ÜÕÀàÎïÖʶÔÉñ¾­¼²²¡¡¢³¦È±ÑªÔÙ¹à×¢¡¢ÌÇÄò²¡Éö²¡¡¢Ö×ÁöµÈ¼²²¡Ò²ÓÐDZÔÚµÄÖÎÁÆ×÷Óá£
 
    ÁÁµã7£ºÄÉÃ×¹è̼¸´ºÏ²ÄÁÏÔØÒ©ÏµÍ³±»ÓÃÓÚÈýÆß¸øÒ©
 
    ÔÚÔØÒ©ÏµÍ³·½Ã棬³ýéÎÆ¤ËØÍ⣬ÈýÆßµÄÄÉÃ×ÔØÒ©ÏµÍ³Ñо¿Ò²È¡µÃÍ»ÆÆ¡£
 
    ÖÚËùÖÜÖª£¬ÉúÈýÆßµÄË®ÈÜÐԽϲÔÚË®ÖÐͨ³£ÒÔÍÅ¿é×´ÐÎ̬´æÔÚ¡£ÈýÆßµÄÒ©Àí×÷Óù㷺£¬³ý¿É´Ù½øÉË¿ÚÓúºÏÍ⣬½üÄ껹·¢ÏÖÆäÔÚÖ×Áö¡¢ÃâÒßÒÖÖÆµÈ¶à·½ÃæµÄÓÃ;£¬µ«ÓÉÓÚÉúÀí»úÖÆ½ÏΪ¸´ÔÓ£¬ÉÐÎÞ·¨µÃµ½½ÏΪÇåÎúµÄ²ûÊö¡£
 
    ÉúÎïÓ«¹âÊÇÔÚÉúÎïѧ½ç¹ã·º²ÉÓõÄ£¬Äܹ»±íÕ÷Ò©Îï·Ö×Ó×÷Ó÷ֲ¼µÄÒ»ÖÖ¼òµ¥¡¢¸ßЧµÄʵÑéÊֶΡ£½üÄêÓжàÖÖÓ«¹âÄÉÃ×ÔØÌåÊܵ½ÁËÉúÎïѧ¼ÒµÄ¹Ø×¢£¬ÓÃÓÚ²ûÊöÊèË®ÐÔ·Ö×Ó£¨ÈçÈýÆß£©µÄÒ©Àí»úÖÆ£¬µ«ÓÉÓÚÕâЩ¸øÒ©ÏµÍ³µÄÉúÎïÀûÓöÈÊܵ½ÏÞÖÆ£¬ºÜ¶àÎÞ·¨µÃµ½¿Í¹Û¡¢ÂúÒâµÄʵÑé½áÂÛ¡£
 
    2019Äê1ÔÂ25ÈÕ£¬ÎÒ¹úËÕÖÝ´óѧµÄºÎÒ«½ÌÊÚÍŶÓÀûÓÃ×ÔÖ÷Ñз¢µÄÐÂÐÍÄÉÃ×¹è̼¸´ºÏ²ÄÁÏ£¬ÔÚ100¡æÎ¢²¨Ìõ¼þÏ·´Ó¦40·ÖÖÓ£¬ÐγÉÁËÇòÐεÄÄÉÃ׿ÅÁ££¬¼ÈÓÕ·¢Á˹èÔ­×ÓÔÚÄÉÃ׳ߴçϵÄÓ«¹âÌØÐÔ£¬Ò²±£Ö¤Á˽ϸߵÄÉúÎïÀûÓöÈ¡£
 
    ¸ÃÀàвÄÁÏÖÆ¼ÁµÄÉË¿ÚÓúºÏÄÜÁ¦ºÍÒÖ¾úÄÜÁ¦Ò²µÃµ½Á˶àÖÖÁÙ´²Ç°ÌåÄÚÍâʵÑéÄ£Ð͵ÄÑéÖ¤£¬Ïà¹Ø³É¹û·¢±íÓÚ¹ú¼ÊºËÐÄÆÚ¿¯¡¶Smal l Group Research¡·¡£
 
    ÁÁµã8£ºÊ¯Ä«Ï©ÉúÎï´«¸ÐÆ÷±»ÓÃÓÚÄ£ÄâÖÐÒ½ÕïÂö
 
    вÄÁϲ»½öÔÚÖÐÒ©µÄÔØÒ©ÏµÍ³ÁìÓòÓÐËù½¨Ê÷£¬ÔÚÖÐÒ½Õï¶ÏÁìÓòÒ²´óչȭ½Å¡£
 
    “ÕïÂö”Ò»Ö±ÊÇÎÒ¹ú´«Í³ÖÐÒ½Õï¶ÏµÄºËÐÄ£¬¶Ô´Ë£¬ÏÖ´ú¿ÆÑ§¼ÒÔÚѹÁ¦´«¸ÐÆ÷·½Ã濪չÁË´óÁ¿Ñо¿£¬µ«½á¹ûÈ´²»¾¡ÈçÈËÒâ¡£¾¿ÆäÔ­Òò£¬ÔÚÈáÐÔ´«¸ÐÆ÷ÁìÓò£¬³ýÁËÒª±£Ö¤´«¸ÐÆ÷µÄÃô¸Ð¶È£¬¸üÖØÒªµÄÊÇʵÏÖÈô«¸ÐÆ÷Ò²¿ÉÒÔÈçÈ˵ÄÖ¸¼âÒ»Ñù¿ÉÒÔ³ÐÊÜ100kPaµÄѹÁ¦¡£
 
    2019Äê8ÔÂ15ÈÕ£¬ÎÒ¹úµç×ӿƼ¼´óѧ¼Ö´ºÑô½ÌÊÚÔÚºËÐĿƼ¼ÆÚ¿¯¡¶Biosensors and Bioelectronics¡··¢±íÎÄÕ¡¶Towards  ultrawide operation range and high sensitivity£º Graphene film based pressur esensors for fingertips¡·£¬ÏÔʾ¸ÃÍŶӲÉÓÃÈÞë״ʯīϩ³É¹¦¿ª·¢ÁËÄܹ»×¼È·Ì½ÖªÑ¹Á¦µÄ´«¸ÐÆ÷¡£
 
    ͨ¹ý²ÄÁÏÐÔÄܲâÊÔ£¬¸ÃÍŶӷ¢ÏÖÈÞë״ʯīϩµÄÁéÃô¶È¿É¾«È·ÖÁ10.39kPa£»¶ø²Ù×÷·¶Î§¿ÉÀ©´óÖÁ200kPa¡£Ñо¿ÈËÔ±Á¢¿ÌÒâʶµ½¸Ã²ÄÁÏÔÚÖÐÒ½ÂöÕïÁìÓòµÄ¸ß¶È¼ÛÖµ£¬²¢Éè¼Æ¿ª·¢ÁËÒÔ´ËвÄÁÏΪºËÐĵÄÖÐÒ½ÂöÕï´«¸ÐÆ÷¡£
 
    ÁÁµã9£º¾í»ýÉñ¾­ÍøÂç½ø¾üÖÐÒ½ÉàÕï
 
    È˹¤ÖÇÄܺÍҽѧµÄ½áºÏÒ»Ö±ÊÇ¿ÆÑÐÁìÓòµÄÈȵ㣬È˹¤ÖÇÄÜÓëÖÐÒ½ÉàÕïµÄ½áºÏ£¬Ò²½«°ÑÖÐÒ½Õï¶Ï¼¼ÊõÌáÉýÖÁеĸ߶ȡ£
 
    2019Äê2Ô£¬¹ú¼ÊºËÐĿƼ¼ÆÚ¿¯¡¶IEEE Transactions on Cybernetics¡·¿¯·¢ÁËÎÒ¹úÉϺ£´óѧ¼ÆËã»ú¹¤³ÌÓë¿ÆÑ§Ñ§ÔºÀîÏþÇ¿ÍŶӵÄ×îгɹû¡¶Tooth-Marked Tongue Recognition Using Multiple Instance Learning and CNN Features¡·¡£
 
    ÎÄÕÂÌá³öÁËÒ»ÖÖ¶àʵÀýµÄÑÀ³Ý±ê¼ÇÉàͷʶ±ð·½·¨¡£¸Ã·½·¨·ÖΪÈý¸ö½×¶Î£ºÊ×ÏÈ£¬Éú³É¿ÉÒÉÇøÓò£»Æä´Î£¬ÀûÓÃÉî¾í»ýÉñ¾­ÍøÂçÌáȡÿ¸öÇøÓòµÄÌØÕ÷£»×îºó£¬ÓÃÒ»×éÌØÕ÷ÏòÁ¿±íʾÉàÍ·£¬ÓöàʵÀýÖ§³ÖÏòÁ¿»ú½øÐÐ×îÖÕ·ÖÀࡣʵÑé½á¹û±íÃ÷£¬¸Ã·½·¨¾«¶È½Ï¸ß£¬²¢ÇÒÔÚÊý¾Ý¼¯ÓÐÔëÉùÇҳݺ۲»Ã÷ÏÔµÄÇé¿öÏÂÒ²ÄܽϺõØÊ¶±ð¡£
 
    ÁÁµã10£ºÏ¸°ûµòÍöÊܹØ×¢
 
    ͨ¹ý¶Ô2019Äê·¢±íÔÚ¹ú¼ÊºËÐÄÆÚ¿¯ÉÏÓйØÖÐÒ½Ò©µÄ¹Ø¼ü´Ê½øÐÐ´ÊÆµÍ³¼Æ·¢ÏÖ£¬Ï¸°ûµòÍö£¨apoptosis£©ÊÇĿǰÖÐÒ½Ò©Ñо¿ÁìÓò×îÊܹØ×¢µÄ¸ÅÄÆä´ÎÊÇÍøÂçÒ©ÀíѧºÍÕë¾ÄµÄÔËÓá£
 
    ¶Ô¸ßƵ´Ê¡¢¹Ø¼ü´ÊÖ®¼äµÄÖ÷Òª¹ØÏµ½øÐÐÊáÀíºó·¢ÏÖ£¬ÖÐÒ½Ò©µÄ»ù´¡¿ÆÑдó¶à¼¯ÖÐÓÚ¶Ô×÷ÓûúÖÆµÄ̽ÌÖ£¬ÆäÖГϸ°ûµòÍö”ΪºËÐÄÉúÎï»úÖÆ£¬Ñ×Ö¢¡¢×ÔÊɺÍÑõ»¯Ó¦¼¤»úÖÆµÄ̽ÌÖ´ó¶àÒ²Î§ÈÆÏ¸°ûµòÍöÕ¹¿ª£¬µ«ÊÇÉæ¼°´úл·ÖÎö¡¢ÍøÂçÒ©Àíѧ¡¢Ëæ»ú¶ÔÕÕÊÔÑéµÈÏÂÓÎÓ¦ÓÃѧ¿ÆÒÔ¼°Õë¾Äʱ£¬ÔòÖ÷ÒªÎ§ÈÆ“Ñ×Ö¢”Õ¹¿ª¡£ÆäÖУ¬Í¬Ê±Éæ¼°“µòÍö”ºÍ“Ñ×Ö¢”µÄ¿ÆÑÐÎÄÏ×ÊýÁ¿×î¶à£¬ÓÐ210ƪ£¬2019ÄêÐÂÔöÕ¼±È26.66%£»Éæ¼°“µòÍö”ºÍ“×ÔÊÉ”µÄÎÄÏ×ÔÚ2019ÄêµÄÔöËÙ×î¿ì£¬´ïµ½ÁË35.25%¡£¶øÔÚÖÐÒ©“Ñ×Ö¢”¸ÅÄîϵÄÉîÈëÑо¿ÖУ¬ÍøÂçÒ©ÀíÑ§Éæ¼°µÄÎÄÏ×ÊýÁ¿×î¶à£¬2019ÄêÔö¼Ó25.81%¡£
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿